# Ryman Hospitality Properties, Inc.: financial statements, quarterly

RHP · NYSE · CIK 1040829 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rhp.md) · [Financials](/companies/rhp/financials.md) · [Filings](/companies/rhp/filings.md) · [Insiders](/companies/rhp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rhp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [529](/filings/0001558370-24-014404.md) | [633 d](/filings/0001104659-26-019035.md) | [528](/filings/0001558370-25-006183.md) | [613](/filings/0001558370-25-010229.md) | [550](/filings/0001104659-25-106165.md) | [648 d](/filings/0001104659-26-019035.md) | [587](/filings/0001104659-26-053780.md) | [660](/filings/0001104659-26-092580.md) | [592](/filings/0001104659-25-106165.md) | [738 d](/filings/0001104659-26-019035.md) | [665](/filings/0001104659-26-053780.md) | [749](/filings/0001104659-26-092580.md) |
| Cost of revenue | $m | [302](/filings/0001558370-24-014404.md) | [381 d](/filings/0001104659-26-019035.md) | [309](/filings/0001558370-25-006183.md) | [317](/filings/0001558370-25-010229.md) | [313](/filings/0001104659-25-106165.md) | [386 d](/filings/0001104659-26-019035.md) | [327](/filings/0001104659-26-053780.md) | [332](/filings/0001104659-26-092580.md) | [350](/filings/0001104659-25-106165.md) | [432 d](/filings/0001104659-26-019035.md) | [374](/filings/0001104659-26-053780.md) | [384](/filings/0001104659-26-092580.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [102](/filings/0001558370-24-014404.md) | [124 d](/filings/0001104659-26-019035.md) | [96.4](/filings/0001558370-25-006183.md) | [168](/filings/0001558370-25-010229.md) | [106](/filings/0001104659-25-106165.md) | [121 d](/filings/0001104659-26-019035.md) | [116](/filings/0001104659-26-053780.md) | [139](/filings/0001104659-26-092580.md) | [88.6](/filings/0001104659-25-106165.md) | [143 d](/filings/0001104659-26-019035.md) | [138](/filings/0001104659-26-053780.md) | [175](/filings/0001104659-26-092580.md) |
| Interest expense | $m | [58.5](/filings/0001558370-23-017957.md) | [61.1 d](/filings/0001558370-24-001613.md) | [60.4](/filings/0001558370-24-006512.md) | [56.6](/filings/0001558370-25-010229.md) | [54.5](/filings/0001104659-25-106165.md) | [53.8 d](/filings/0001104659-26-019035.md) | [54.3](/filings/0001104659-26-053780.md) | [58.5](/filings/0001104659-26-092580.md) | [64.9](/filings/0001104659-25-106165.md) | [63.6 d](/filings/0001104659-26-019035.md) | [64.1](/filings/0001104659-26-053780.md) | [63.9](/filings/0001104659-26-092580.md) |
| Income tax | $m | [2.2](/filings/0001558370-24-014404.md) | [(101) d](/filings/0001104659-26-019035.md) | [0.5](/filings/0001558370-25-006183.md) | [12.2](/filings/0001558370-25-010229.md) | [0.9](/filings/0001104659-25-106165.md) | [0.2 d](/filings/0001104659-26-019035.md) | [4.2](/filings/0001104659-26-053780.md) | [7.8](/filings/0001104659-26-092580.md) | [(3.6)](/filings/0001104659-25-106165.md) | [(1.1) d](/filings/0001104659-26-019035.md) | [6.9](/filings/0001104659-26-053780.md) | [12.1](/filings/0001104659-26-092580.md) |
| Net income | $m | [40.8](/filings/0001558370-24-014404.md) | [139 d](/filings/0001104659-26-019035.md) | [42.8](/filings/0001558370-25-006183.md) | [101](/filings/0001558370-25-010229.md) | [59.0](/filings/0001104659-25-106165.md) | [68.8 d](/filings/0001104659-26-019035.md) | [63.0](/filings/0001104659-26-053780.md) | [71.8](/filings/0001104659-26-092580.md) | [34.9](/filings/0001104659-25-106165.md) | [73.8 d](/filings/0001104659-26-019035.md) | [70.5](/filings/0001104659-26-053780.md) | [92.8](/filings/0001104659-26-092580.md) |
| Diluted EPS | $ per share | [0.64](/filings/0001558370-24-014404.md) | not reported | [0.67](/filings/0001558370-25-006183.md) | [1.65](/filings/0001558370-25-010229.md) | [0.94](/filings/0001104659-25-106165.md) | not reported | [1.00](/filings/0001104659-26-053780.md) | [1.12](/filings/0001104659-26-092580.md) | [0.53](/filings/0001104659-25-106165.md) | not reported | [1.03](/filings/0001104659-26-053780.md) | [1.42](/filings/0001104659-26-092580.md) |
| Basic EPS | $ per share | [0.69](/filings/0001558370-24-014404.md) | not reported | [0.72](/filings/0001558370-25-006183.md) | [1.68](/filings/0001558370-25-010229.md) | [0.99](/filings/0001104659-25-106165.md) | not reported | [1.05](/filings/0001104659-26-053780.md) | [1.17](/filings/0001104659-26-092580.md) | [0.55](/filings/0001104659-25-106165.md) | not reported | [1.12](/filings/0001104659-26-053780.md) | [1.47](/filings/0001104659-26-092580.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [543](/filings/0001558370-24-014404.md) | [592](/filings/0001104659-26-019035.md) | [465](/filings/0001558370-25-006183.md) | [498](/filings/0001558370-25-010229.md) | [535](/filings/0001104659-25-106165.md) | [478](/filings/0001104659-26-019035.md) | [414](/filings/0001104659-26-053780.md) | [421](/filings/0001104659-26-092580.md) | [483](/filings/0001104659-25-106165.md) | [471](/filings/0001104659-26-092580.md) | [424](/filings/0001104659-26-053780.md) | [366](/filings/0001104659-26-092580.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [5,064](/filings/0001558370-23-017957.md) | [5,189](/filings/0001558370-25-001286.md) | [5,089](/filings/0001558370-24-006512.md) | [5,140](/filings/0001558370-24-010587.md) | [5,204](/filings/0001558370-24-014404.md) | [5,218](/filings/0001104659-26-019035.md) | [5,239](/filings/0001558370-25-006183.md) | [6,111](/filings/0001558370-25-010229.md) | [6,197](/filings/0001104659-25-106165.md) | [6,181](/filings/0001104659-26-092580.md) | [6,194](/filings/0001104659-26-053780.md) | [6,192](/filings/0001104659-26-092580.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [4,253](/filings/0001558370-23-017957.md) | [4,271](/filings/0001558370-25-001286.md) | [4,202](/filings/0001558370-24-006512.md) | [4,211](/filings/0001558370-24-010587.md) | [4,277](/filings/0001558370-24-014404.md) | [4,283](/filings/0001104659-26-019035.md) | [4,277](/filings/0001558370-25-006183.md) | [4,867](/filings/0001558370-25-010229.md) | [4,987](/filings/0001104659-25-106165.md) | [4,969](/filings/0001104659-26-092580.md) | [4,990](/filings/0001104659-26-053780.md) | [4,957](/filings/0001104659-26-092580.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [471](/filings/0001558370-23-017957.md) | [569](/filings/0001558370-25-001286.md) | [530](/filings/0001558370-24-006512.md) | [563](/filings/0001558370-24-010587.md) | [552](/filings/0001558370-24-014404.md) | [549](/filings/0001104659-26-019035.md) | [532](/filings/0001558370-25-006183.md) | [800](/filings/0001558370-25-010229.md) | [758](/filings/0001104659-25-106165.md) | [750](/filings/0001104659-26-092580.md) | [733](/filings/0001104659-26-053780.md) | [748](/filings/0001104659-26-092580.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [154 d](/filings/0001558370-24-014404.md) | [187 d](/filings/0001104659-26-019035.md) | [7.5](/filings/0001558370-25-006183.md) | [184 d](/filings/0001558370-25-010229.md) | [218 d](/filings/0001104659-25-106165.md) | [167 d](/filings/0001104659-26-019035.md) | [98.2](/filings/0001104659-26-053780.md) | [123 d](/filings/0001104659-26-092580.md) | [205 d](/filings/0001104659-25-106165.md) | [165 d](/filings/0001104659-26-019035.md) | [169](/filings/0001104659-26-053780.md) | [153 d](/filings/0001104659-26-092580.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [60.1 d](/filings/0001558370-24-014404.md) | [60.1 d](/filings/0001104659-26-019035.md) | [67.1](/filings/0001558370-25-006183.md) | [66.3 d](/filings/0001558370-25-010229.md) | [66.3 d](/filings/0001104659-25-106165.md) | [66.4 d](/filings/0001104659-26-019035.md) | [70.3](/filings/0001104659-26-053780.md) | [69.5 d](/filings/0001104659-26-092580.md) | [72.9 d](/filings/0001104659-25-106165.md) | [72.9 d](/filings/0001104659-26-019035.md) | [77.5](/filings/0001104659-26-053780.md) | [76.2 d](/filings/0001104659-26-092580.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [59.3](/filings/0001558370-23-017957.md) | [59.3](/filings/0001558370-24-006512.md) | [60.5](/filings/0001558370-24-010587.md) | [63.6](/filings/0001558370-24-014404.md) | [63.4](/filings/0001558370-25-006183.md) | [63.2](/filings/0001558370-25-010229.md) | [63.9](/filings/0001104659-25-106165.md) | [63.8](/filings/0001104659-26-053780.md) | [65.7](/filings/0001104659-26-092580.md) | [67.3](/filings/0001104659-25-106165.md) | [67.7](/filings/0001104659-26-053780.md) | [68.1](/filings/0001104659-26-092580.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,119,288 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092580.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.